Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline
- DOI
- 10.1093/ofid/ofaf615
- Published
- 2025-10-06
- Container
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ofid/ofaf615,
title = {Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline},
author = {Karam Mounzer and Jihad Slim and Moti Ramgopal and Malcolm Hedgcock and Mark Bloch and Jorge Santana and Keith Aizen and Xu Zhang and Peter Sklar and Jairo M Montezuma-Rusca and Sorana Segal-Maurer},
year = {2025},
journal = {Open Forum Infectious Diseases},
doi = {10.1093/ofid/ofaf615},
url = {https://doi.org/10.1093/ofid/ofaf615}
}RIS
TY - JOUR TI - Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline AU - Karam Mounzer AU - Jihad Slim AU - Moti Ramgopal AU - Malcolm Hedgcock AU - Mark Bloch AU - Jorge Santana AU - Keith Aizen AU - Xu Zhang AU - Peter Sklar AU - Jairo M Montezuma-Rusca AU - Sorana Segal-Maurer PY - 2025 JO - Open Forum Infectious Diseases DO - 10.1093/ofid/ofaf615 UR - https://doi.org/10.1093/ofid/ofaf615 ER -
APA
Mounzer, K., Slim, J., Ramgopal, M., Hedgcock, M., Bloch, M., Santana, J., Aizen, K., Zhang, X., Sklar, P., Montezuma-Rusca, J. M., & Segal-Maurer, S. (2025). Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofaf615
Source records
- crossref · retrieved 2026-09-26T06:14:46.793Z